Revvity Share Price Today
(NASDAQ: RVTY)

Name: Revvity Share Price Today (NASDAQ: RVTY) - Revvity Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Revvity share price is $111.73 & ₹9,717.05 as on 6 Mar 2025, 2.30 'hrs' IST

$111.73

▲

2.47

(2.26%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Revvity share price in Dollar and Rupees. Guide to invest in Revvity stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Revvity, along with analyst recommendations, forecasts, and comprehensive financials.

Revvity share price movements

Today's Low: $108.55
Today's High: $111.81
$111.73
2.85%
Downside
Day's Volatility :2.92%
Upside
0.07%
52 Weeks Low: $97.32
52 Weeks High: $129.50
$111.73
12.9%
Downside
52 Weeks Volatility :24.85%
Upside
13.72%

Revvity (RVTY) Returns

Period	Revvity Inc	Index (Russel 2000)
3 Months	-5.07%	0.0%
6 Months	-6.71%	0.0%
1 Year	1.82%	0.0%
3 Years	-36.57%	-11.6%

Revvity (RVTY) Key Statistics

in dollars & INR

Previous Close	$109.26
Open	$108.85
Today's High	$111.81
Today's Low	$108.545
Market Capitalization	$13.3B
Today's Volume	$336.0K
52 Week High	$129.5
52 Week Low	$97.315
Revenue TTM	$2.8B
EBITDA	$837.6M
Earnings Per Share (EPS)	$2.3
PE Ratio	48.0
Dividend Yield	0.25%
Profit Margin	9.81%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	3.64%

How to invest in Revvity Stock (RVTY) from India?

It is very easy for Indian residents to invest directly in Revvity from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Revvity stock in both Indian Rupees (INR) and US Dollars (USD). Search for Revvity or RVTY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Revvity or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Revvity shares which would translate to 0.008 fractional shares of Revvity as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Revvity, in just a few clicks!

Returns in Revvity (RVTY) for Indian investors in Rupees

The Revvity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Revvity investment value today

Current value as on today

₹1,09,082

Returns

₹9,082

(+9.08%)

Returns from Revvity Stock

₹4,119 (+4.12%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Revvity (RVTY)

31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Revvity Stock from India on INDmoney has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Revvity

Buy

64%Buy

36%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Revvity(by analysts ranked 0 to 5 stars)

Based on 25 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Revvity Stock (RVTY)

What analysts predicted

Upside of 26.37%

Target:

$141.19

Current:

$111.73

Insights on Revvity Stock (Ticker Symbol: RVTY)

Price Movement
In the last 1 month, RVTY stock has moved down by -10.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 684.04M → 729.37M (in $), with an average increase of 6.2% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, 26.01M → 94.64M (in $), with an average increase of 27.9% per quarter
RVTY vs TMO (3 yr)
In the last 3 years, Revvity Inc has experienced a drawdown of -38.1%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 32.5%

RVTY Revvity Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.9B	↑ 3.8%
Net Income	$227.6M	↓ 4.36%
Net Profit Margin	7.89%	↓ 0.67%

	FY20	Y/Y Change
Revenue	$3.8B	↑ 31.18%
Net Income	$727.9M	↑ 219.87%
Net Profit Margin	19.24%	↑ 11.35%

	FY21	Y/Y Change
Revenue	$5.1B	↑ 33.95%
Net Income	$943.2M	↑ 29.57%
Net Profit Margin	18.61%	↓ 0.63%

	FY22	Y/Y Change
Revenue	$3.3B	↓ 34.64%
Net Income	$569.2M	↓ 39.65%
Net Profit Margin	17.19%	↓ 1.42%

	FY23	Y/Y Change
Revenue	$2.8B	↓ 16.95%
Net Income	$693.1M	↑ 21.77%
Net Profit Margin	25.2%	↑ 8.01%

	FY24	Y/Y Change
Revenue	$2.8B	↑ 0.16%
Net Income	$270.4M	↓ 60.99%
Net Profit Margin	9.81%	↓ 15.39%

	Q3 FY23	Q/Q Change
Revenue	$670.7M	↓ 5.41%
Net Income	$9.5M	↓ 73.29%
Net Profit Margin	1.42%	↓ 3.59%

	Q4 FY23	Q/Q Change
Revenue	$695.9M	↑ 3.75%
Net Income	$78.6M	↑ 727.24%
Net Profit Margin	11.29%	↑ 9.87%

	Q1 FY24	Q/Q Change
Revenue	$649.9M	↓ 6.61%
Net Income	$26.0M	↓ 66.89%
Net Profit Margin	4.0%	↓ 7.29%

	Q2 FY24	Q/Q Change
Revenue	$691.7M	↑ 6.43%
Net Income	$79.1M	↑ 204.11%
Net Profit Margin	11.44%	↑ 7.44%

	Q3 FY24	Q/Q Change
Revenue	$684.0M	↓ 1.1%
Net Income	$93.4M	↑ 18.05%
Net Profit Margin	13.65%	↑ 2.21%

	Q4 FY24	Q/Q Change
Revenue	$729.4M	↑ 6.63%
Net Income	$94.6M	↑ 1.35%
Net Profit Margin	12.98%	↓ 0.67%

	FY19	Y/Y Change
Profit	$1.4B	↑ 4.11%

	FY20	Y/Y Change
Profit	$2.1B	↑ 51.13%

	FY21	Y/Y Change
Profit	$2.9B	↑ 35.14%

	FY22	Y/Y Change
Profit	$2.0B	↓ 30.21%

	FY23	Y/Y Change
Profit	$1.5B	↓ 22.62%

	FY24	Y/Y Change
Profit	$1.5B	↓ 0.13%

	Q3 FY23	Q/Q Change
Profit	$372.5M	↓ 7.41%

	Q4 FY23	Q/Q Change
Profit	$293.9M	↓ 21.12%

	Q1 FY24	Q/Q Change
Profit	$263.8M	↓ 10.22%

	Q2 FY24	Q/Q Change
Profit	$385.5M	↑ 46.13%

	Q3 FY24	Q/Q Change
Profit	$384.8M	↓ 0.18%

	Q4 FY24	Q/Q Change
Profit	$412.3M	↑ 7.14%

	FY19	Y/Y Change
Operating Cash Flow	$363.5M	↑ 16.86%
Investing Cash Flow	$-487.6M	-
Financing Cash Flow	$150.1M	↓ 183.76%

	FY20	Y/Y Change
Operating Cash Flow	$892.2M	↑ 145.46%
Investing Cash Flow	$-504.5M	↑ 3.47%
Financing Cash Flow	$-202.9M	↓ 235.13%

	FY21	Y/Y Change
Operating Cash Flow	$1.4B	↑ 58.12%
Investing Cash Flow	$-4.1B	↑ 715.22%
Financing Cash Flow	$2.9B	↓ 1550.01%

	FY22	Y/Y Change
Operating Cash Flow	$679.8M	↓ 51.81%
Investing Cash Flow	$-132.9M	↓ 96.77%
Financing Cash Flow	$-661.8M	↓ 122.5%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-33.5M	↓ 75.25%
Investing Cash Flow	$434.9M	↓ 176.15%
Financing Cash Flow	$-586.0M	↑ 156.73%

Revvity Technicals Summary

Sell

Neutral

Buy

Revvity is currently in a neutral trading position according to technical analysis indicators.

Revvity (RVTY) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Revvity Inc	-11.67%	-6.71%	1.82%	-36.57%	41.11%
Agilent Technologies Inc.	-16.31%	-11.06%	-15.84%	-5.59%	73.94%
Idexx Laboratories, Inc.	-5.04%	-5.88%	-20.78%	-14.63%	81.86%
Thermo Fisher Scientific, Inc.	-11.02%	-14.88%	-12.67%	-3.4%	74.9%
Danaher Corp.	-4.23%	-22.21%	-18.58%	-21.71%	45.43%
Iqvia Holdings Inc.	-8.23%	-26.02%	-27.43%	-15.27%	48.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Revvity Inc	48.0	48.0	0.8	4.95	0.04	0.02	0.0	63.55
Agilent Technologies Inc.	28.22	28.22	2.06	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.97	40.97	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.62	31.62	2.05	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.81	38.81	2.07	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.51	24.51	0.99	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Revvity Inc	Buy	$13.3B	41.11%	48.0	9.81%
Agilent Technologies Inc.	Buy	$35.1B	73.94%	28.22	19.27%
Idexx Laboratories, Inc.	Buy	$35.6B	81.86%	40.97	22.78%
Thermo Fisher Scientific, Inc.	Buy	$197.5B	74.9%	31.62	14.77%
Danaher Corp.	Buy	$147.0B	45.43%	38.81	16.33%
Iqvia Holdings Inc.	Buy	$32.4B	48.04%	24.51	8.91%

Revvity Dividend announcements

Revvity Dividends June, 2025
In the quarter ending June,2025. Revvity has declared dividend of $0.07

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Organization	Revvity
Employees	11000
CEO	Dr. Prahlad R. Singh Ph.D.
Industry	Miscellaneous

Management People of Revvity

Name	Title
Dr. Prahlad R. Singh Ph.D.	CEO, President & Director
Mr. Maxwell Krakowiak	Senior VP & CFO
Mr. Tajinder S. Vohra	Senior Vice President of Global Operations
Mr. Joel S. Goldberg	Senior VP of Administration, General Counsel & Secretary
Ms. Miriame Victor	Senior VP & Chief Commercial Officer
Mr. Bryan A. Kipp	Senior VP of Technology & Licensing
Ms. Madhuri Hegde FACMG, Ph.D.	Senior VP & Chief Scientific Officer
Mr. Stephen Barr Willoughby	Senior VP of Investor Relations & Head of ESG
Ms. Magali Four	Senior VP and Chief People & Culture Officer
Mr. Robert Francis Friel	Advisor

Important FAQs about investing in RVTY Stock from India :

What is Revvity share price today?

Revvity share price today stands at $111.73, Open: $108.85 ; Previous Close: $109.26 ; High: $111.81 ; Low: $108.55 ; 52 Week High: $129.50 ; 52 Week Low: $97.32.

The stock opens at $108.85, after a previous close of $109.26. The stock reached a daily high of $111.81 and a low of $108.55, with a 52-week high of $129.50 and a 52-week low of $97.32.

Can Indians buy Revvity shares?

Yes, Indians can invest in the Revvity (RVTY) from India.

With INDmoney, you can buy Revvity at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Revvity at zero transaction cost.

How can I buy Revvity shares from India?

It is very easy to buy Revvity from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Revvity (RVTY) be purchased?

Yes, you can buy fractional shares of Revvity with INDmoney app.

What are the documents required to start investing in Revvity stocks?

To start investing in Revvity, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.